Discount Agreement for Omalizumab (ATC L04AG08)
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Omalizumab, ATC L04AG08 für die Zeit 01.08.2026 - 31.07.2028
Status
Active
Submission Deadline
640 days remaining
Contracting authority
DAK-Gesundheit226 more open tenders view
Location
Hamburg, Germany
Estimated Value
€1
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
bkms-ef-4d0745e1-4dce-449c-a39d-6352edce83d4
Source
Enter into a non-exclusive discount agreement for Omalizumab (ATC L04AG08) with DAK-Gesundheit. This agreement is valid from 08/01/2026 to 07/31/2028, allowing all interested pharmaceutical companies to participate.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- SomeTenderDocID1NON-RESTRICTED-DOCUMENT
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
Legal Basis
32014L0024